Landmark Statement of Declaration: A €500,000 Boost for Vaccine Localization
In a significant development for Egypt’s healthcare future, the Egyptian Authority for Unified Procurement and Medical Technology Management (UPA) and the European Union, represented by the European Commission Delegation to Egypt, have signed a Statement of Declaration. This crucial agreement earmarks €500,000 (Five Hundred Thousand Euros) from the EU Commission to bolster the development of Egypt’s National Strategy for Vaccine Manufacturing Localization.
Under the auspices of the Ministry of International Cooperation, this collaboration signifies a robust commitment to achieving self-sufficiency in health products for Egypt. The UPA is entrusted with the implementation of this vital strategy, with the EVMA serving as its executive arm.
The overall objective of this initiative is to sustainably implement national plans aimed at achieving local self-sufficiency in health product manufacturing and ensuring equitable access for the population, thereby contributing to the Global Health Strategy. Specifically, this partnership will support the demand and supply of locally produced goods, including forecasting, procurement, and distribution of health products.
The EU Commission, with the support of the UPA, will be responsible for the successful execution and delivery of the National Strategy for Vaccine Manufacturing Localization. This includes overseeing and ensuring the completion of several key deliverables, such as:
- An updated Egypt National Strategy for Vaccine Manufacturing Localization (2024-2030) and its implementation plan.
- Development of a detailed implementation plan outlining annual financial capital costs, investment strategies, technology transfer frameworks, and procurement roadmaps.
- Strategic recommendations for aligning regulatory frameworks with WHO, EMA, and Africa CDC standards to expedite vaccine approvals.
- Establishment of a framework to support sustainable Public-Private Partnerships (PPPs) with legal structures for technology transfer and investment protection.
- Development and implementation of comprehensive training initiatives to enhance regulatory competence and manufacturing capabilities, including EU-Africa knowledge exchange.
- Formulation of a digitalization strategy, including a plan for digital tools and platforms to support technology transfer, regulatory compliance, and knowledge-sharing.
- Development of strategies for expanding Egypt’s vaccine market within AfCFTA and COMESA regions, leveraging the African Pooled Procurement Mechanism (APPM).
- Submission of key reports and deliverables as detailed in the Terms of Reference.
Both the EU Commission and the UPA have committed to close collaboration and coordination throughout this initiative to ensure its effective and efficient implementation. This Statement of Declaration underscores the mutual understanding and commitment of all parties towards the successful development and implementation of the National Strategy for Vaccine Manufacturing Localization in Egypt.
This landmark partnership, combined with EVMA’s continued efforts, marks a significant step forward in securing Egypt’s and the region’s health future through robust local vaccine manufacturing.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
